Century Therapeutics, Inc. (IPSC)
NASDAQ: IPSC · Real-Time Price · USD
0.5003
-0.0299 (-5.64%)
Apr 25, 2025, 4:00 PM EDT - Market closed
IPSC's stock price has decreased by -83.1% in the past year and price targets may not have had time to catch up.
Century Therapeutics Analyst Ratings
Total Analysts
5
Consensus Rating
Strong Buy
Price Target
$3.67
Upside
+633.56%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $5 → $2 | Strong Buy | Maintains | $5 → $2 | +299.76% | Apr 3, 2025 |
Guggenheim | Guggenheim | Strong Buy Reiterates n/a | Strong Buy | Reiterates | n/a | n/a | Mar 28, 2025 |
Chardan Capital | Chardan Capital | Strong Buy Maintains $11 → $7 | Strong Buy | Maintains | $11 → $7 | +1,299.16% | Mar 24, 2025 |
Guggenheim | Guggenheim | Strong Buy Maintains $12 → $5 | Strong Buy | Maintains | $12 → $5 | +899.40% | Mar 21, 2025 |
Piper Sandler | Piper Sandler | Buy Maintains $4 → $2 | Buy | Maintains | $4 → $2 | +299.76% | Mar 20, 2025 |
Guggenheim | Guggenheim | Strong Buy Reiterates n/a | Strong Buy | Reiterates | n/a | n/a | Jan 22, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $5 | Strong Buy | Reiterates | $5 | +899.40% | Jan 22, 2025 |
Piper Sandler | Piper Sandler | Buy Maintains $12 → $4 | Buy | Maintains | $12 → $4 | +699.52% | Dec 30, 2024 |
Chardan Capital | Chardan Capital | Strong Buy Maintains $17 → $11 | Strong Buy | Maintains | $17 → $11 | +2,098.68% | Nov 7, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $9 → $5 | Strong Buy | Maintains | $9 → $5 | +899.40% | Nov 6, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $11 → $9 | Strong Buy | Maintains | $11 → $9 | +1,698.92% | Aug 15, 2024 |
Piper Sandler | Piper Sandler | Buy Maintains $9 → $12 | Buy | Maintains | $9 → $12 | +2,298.56% | Jun 17, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +2,098.68% | Jun 4, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $13 → $11 | Strong Buy | Maintains | $13 → $11 | +2,098.68% | May 10, 2024 |
Piper Sandler | Piper Sandler | Buy Reiterates $10 → $9 | Buy | Reiterates | $10 → $9 | +1,698.92% | Apr 12, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $13 | Strong Buy | Reiterates | $13 | +2,498.44% | Mar 15, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.